Payers acknowledge obesity as a public health issue and are working to establish offerings that align with USPSTF recommendations in order to treat and prevent obesity, says Jenny Bogard, MPH, director of healthcare strategies at the Alliance for a Healthier Generation.
Payers acknowledge obesity as a public health issue and are working to establish offerings that align with USPSTF recommendations in order to treat and prevent obesity, says Jenny Bogard, MPH, director of healthcare strategies at the Alliance for a Healthier Generation.
Transcript (slightly modified)
What work are you doing with payers to help combat childhood obesity?
We recently launched an obesity prevention and treatment payer taskforce, last October. This was in collaboration with the Bipartisan Policy Center, the Institute of Medicine, which is now the National Academies of Science, and the American College of Sports Medicine. We brought together a collective group of payers and Medicaid state plans to really talk about aligning benefits to the United States Preventive Services Task Force recommendations and we’re working together right now to develop a pledge where we hope to make a formal announcement, later in the fall, with our partners and with the participants.
Again, this is really extending our legacy program which is the Healthier Generation Benefit, where we focus just on pediatric obesity, but really broadening it to adult obesity, as well, and inviting multiple new stakeholders to come to the table so that we can universally agree upon what set of offerings should be available to people to treat and prevent obesity.
How has payer involvement in obesity treatment and prevention evolved in the last few years?
Over the last several years, payers have recognized that obesity is a critical public health challenge, so they know they have to do something. They also know that they have to align their benefit offerings to the United States Preventive Task Force recommendations. We kind of help them do that and reach their goals internally to do that as an organization. They also recognize, as I said earlier, is that obesity is related to multiple chronic conditions and that they need to address obesity and the root of the cause so they can really see impactful change.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More